The global Live Cell Imaging market size is expected to be worth around US$ 19.0 billion by 2030, according to a new report by Vision Research Reports.
The global Live Cell Imaging market size was valued at US$ 14.3 billion in 2020 and is anticipated to grow at a CAGR of 18.5% during forecast period 2021 to 2030.
The rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.
In a survey by Drug Discovery World Spring, almost 21% of researchers prefer & use live cell imaging, and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.
Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased the use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.
Based on the product, the market is segmented into equipment, consumables, and software used in live cell imaging. The equipment segment dominated the market in 2020, which was followed by consumables. The equipment segment includes microscopes, cell analyzers, image capturing systems, and standalone systems.
Extensive research being conducted to develop microscopes of higher resolution is likely to boost the market over the forecast period. New technologies such as inverted research-grade microscopes have enabled imaging of adherent cells and organelles and yield results for tissue sections of less than 5 um thickness. New developments are also allowing imaging of the cells in spatial resolutions within a time range.
Consumables play an important role in optimizing the yielded results. The optimal dye, probes, and medium are crucial for time-lapse imaging wherein the cells are exposed for a long duration. The potency of cells may negatively be affected by the wrong choice of medium. Many industry players such as Thermo Fisher and Enzium Inc are active in the market.
The overall industry trend is shifting toward automation, integration of systems, and maximizing the data generation from the microscopes. The increasing use of live cell imaging amongst cell biologists to understand the fundamental nature of the cell function and structure has resulted in this shift.
The market is segmented by application as cell biology, developmental biology, stem cell & drug discovery, and others. Cell biology dominated the application segment due to the rising number of researchers working on molecular interaction networks. Innovations such as filter techniques and advanced illumination devices further enable the procedure. Cell biologists utilize live cell imaging to understand the fundamental cellular structures and their interaction on the tissue level. Advantages such as clarity of structural components and spatial heterogeneity of a cell offered by live cell imaging are anticipated to further boost the market.
Developmental biology also followed closely cell biology in terms of application due to the use of live cell imaging in observation of cell embryogenesis and to study the physiological state of the cell. It allows researchers to view the cell activity and proliferation throughout the developmental procedure. The other applications of the imaging technique include fields such as drug genetics, neurobiology, immunology, and microbiology. Advancements in these fields are also expected to contribute to growth in the coming years.
On the basis of technology, the market is categorized as time-lapse microscopy, Fluorescence Recovery After Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High Content Screening (HCS), and others. FRET dominated the technology segment in 2015 due to the advantage offered by it in determining the spatial proximity at the protein level, which cannot be achieved by fluorescence microscopy. This technology has gained popularity in recent years due to its rising application in genetic targeting peptides.
The segment is also strengthened by newly launched products by industry players. For instance, in November 2016, Merck launched a new microfluidic system, CellASIC ONIX2, intended to be used for live cell imaging. The product is perceived to offer better cell manipulation techniques and stable imaging conditions. Moreover, in 2015, Enzo Life Sciences, Inc. launched quencher dyes that are utilized in FRET imaging. Similarly, a new photostable dye was developed by researchers at Nagoya University in October 2015. This dye was intended to use in STED live cell imaging.
North America dominated by market share in 2020 closely followed by Europe. Generous investments and funding available for research in this field is the key driver in this region. In December 2016, the Government of Canada announced funding worth USD 8 million to support the Canada Research Chairs Program. This fund was a part of total funding worth more than USD 164 million allocated for infrastructure. Projects on live cell imaging in plant development, which are undertaken by McGill University are included under this program.
Europe also held a major share due to early adoption of technology. The growing aging population demands for intensive research in chronic diseases such as cancer, neurodegeneration, and cardiac diseases. This has favored stem cell research and advanced microscopy. Institutes such as Cancer Research UK and Wellcome Trust are increasingly funding research in cell and developmental biology. In December 2016, the trust committed a fund worth USD 143 million to support 14 research centers over the period of the next 5 years.
Private research institutes and universities are working toward making the technology accessible and to yield faster results. In December 2020, Uppsala University published a study to show the use of smartphones in live cell imaging and its feasibility This will eliminate the need for expensive equipment and consumables.
Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific, Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC.
Stem Cell & Drug Discovery
Fluorescence recovery after photobleaching (FRAP)
Fluorescence resonance energy transfer (FRET)
High content screening (HCS)
The Live Cell Imaging market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Live Cell Imaging market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Live Cell Imaging market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Live Cell Imaging market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Live Cell Imaging market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Live Cell Imaging capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Live Cell Imaging by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Live Cell Imaging market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Live Cell Imaging market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Live Cell Imaging market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Live Cell Imaging industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Live Cell Imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Live Cell Imaging market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Live Cell Imaging market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Live Cell Imaging market. These factors have benefited the growth of the global market for Live Cell Imaging. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Live Cell Imaging. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Live Cell Imaging are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...
Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030Read more...